Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Daya

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 1, 1994
Eclampsia: a continuing problem in developing countriesJ Moodley, P Daya
SADJ : Journal of the South African Dental Association = Tydskrif Van Die Suid-Afrikaanse Tandheelkundige Vereniging|June 9, 2004
Penetrating stab wound injuries to the faceNilesh P Daya, Heidi L Liversage
Oral Microbiology and Immunology|November 7, 1999
Mutans streptococci and other caries-associated acidogenic bacteria in five-year-old children in South AfricaC S Toi, P E Cleaton-Jones, N P Daya
Brain Research|August 6, 2011
Alpha-phenyl-N-tert-butylnitrone prevents oxidative stress in a haloperidol-induced animal model of tardive dyskinesia: investigating the behavioural and biochemical changesRitesh P Daya, Mattea L Tan, Christal D Sookram, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 5, 2012
PAOPA, a potent dopamine D2 receptor allosteric modulator, prevents and reverses behavioral and biochemical abnormalities in an amphetamine-sensitized preclinical animal model of schizophreniaMichael G R Beyaert, Ritesh P Daya, Bailey A Dyck, et al.
Neuropharmacology|October 22, 2013
Effects of MK-801 treatment across several pre-clinical analyses including a novel assessment of brain metabolic function utilizing PET and CT fused imaging in live ratsR P Daya, J K Bhandari, P A Hui, et al.
Schizophrenia Research|February 21, 2012
Behavioral effects of non-viral mediated RNA interference of synapsin II in the medial prefrontal cortex of the ratBailey A Dyck, Mattea L Tan, Ritesh P Daya, et al.
Molecular Pharmaceutics|July 31, 2015
Brain Targeting of a Water Insoluble Antipsychotic Drug Haloperidol via the Intranasal Route Using PAMAM DendrimerYogesh K Katare, Ritesh P Daya, Christal Sookram Gray, et al.
Frontiers in Behavioral Neuroscience|January 9, 2019
The Dopamine Allosteric Agent, PAOPA, Demonstrates Therapeutic Potential in the Phencyclidine NMDA Pre-clinical Rat Model of SchizophreniaRitesh P Daya, Jayant Bhandari, Sharnpreet K Kooner, et al.
Schizophrenia Research|December 4, 2016
Intranasal delivery of antipsychotic drugsYogesh K Katare, Justin E Piazza, Jayant Bhandari, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 1, 1994
Eclampsia: a continuing problem in developing countriesJ Moodley, P Daya
SADJ : Journal of the South African Dental Association = Tydskrif Van Die Suid-Afrikaanse Tandheelkundige Vereniging|June 9, 2004
Penetrating stab wound injuries to the faceNilesh P Daya, Heidi L Liversage
Oral Microbiology and Immunology|November 7, 1999
Mutans streptococci and other caries-associated acidogenic bacteria in five-year-old children in South AfricaC S Toi, P E Cleaton-Jones, N P Daya
Brain Research|August 6, 2011
Alpha-phenyl-N-tert-butylnitrone prevents oxidative stress in a haloperidol-induced animal model of tardive dyskinesia: investigating the behavioural and biochemical changesRitesh P Daya, Mattea L Tan, Christal D Sookram, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 5, 2012
PAOPA, a potent dopamine D2 receptor allosteric modulator, prevents and reverses behavioral and biochemical abnormalities in an amphetamine-sensitized preclinical animal model of schizophreniaMichael G R Beyaert, Ritesh P Daya, Bailey A Dyck, et al.
Neuropharmacology|October 22, 2013
Effects of MK-801 treatment across several pre-clinical analyses including a novel assessment of brain metabolic function utilizing PET and CT fused imaging in live ratsR P Daya, J K Bhandari, P A Hui, et al.
Schizophrenia Research|February 21, 2012
Behavioral effects of non-viral mediated RNA interference of synapsin II in the medial prefrontal cortex of the ratBailey A Dyck, Mattea L Tan, Ritesh P Daya, et al.
Molecular Pharmaceutics|July 31, 2015
Brain Targeting of a Water Insoluble Antipsychotic Drug Haloperidol via the Intranasal Route Using PAMAM DendrimerYogesh K Katare, Ritesh P Daya, Christal Sookram Gray, et al.
Frontiers in Behavioral Neuroscience|January 9, 2019
The Dopamine Allosteric Agent, PAOPA, Demonstrates Therapeutic Potential in the Phencyclidine NMDA Pre-clinical Rat Model of SchizophreniaRitesh P Daya, Jayant Bhandari, Sharnpreet K Kooner, et al.
Schizophrenia Research|December 4, 2016
Intranasal delivery of antipsychotic drugsYogesh K Katare, Justin E Piazza, Jayant Bhandari, et al.
Pageof 2